Literature DB >> 27166243

Psychosocial Profile and Quality of Life in Children With Type 1 Narcolepsy: A Case-Control Study.

Francesca Letizia Rocca1, Elena Finotti2, Fabio Pizza3,4, Francesca Ingravallo5, Michela Gatta6, Oliviero Bruni7, Giuseppe Plazzi3,4.   

Abstract

STUDY
OBJECTIVES: To investigate behavioral aspects and quality of life in children and adolescents with type 1 narcolepsy (NT1).
METHODS: We performed a case-control study comparing 29 patients with NT1 versus sex- and age-matched patients with idiopathic epilepsy (n = 39) and healthy controls (n = 39). Behavior and quality of life were evaluated by self-administered questionnaires (Child Behavior Checklist, Pediatric Quality of Life Inventory). Patient groups were contrasted and scale results were correlated with clinical and polysomnographic parameters, and cerebrospinal fluid hypocretin-1 levels.
RESULTS: Young patients with NT1 showed increased internalizing problems associated with aggressive behavior. Emotional profile in patients with NT1 positively correlated with age at onset, diagnostic delay, and subjective sleepiness, whereas treatment and disease duration were associated with fewer behavioral problems (attention problems, aggressive behavior, and attention deficit/hyperactivity disorder). Psychosocial health domains of pediatric NT1 were worse than in healthy controls, whereas the physical health domains were comparable.
CONCLUSIONS: Young NT1 patients show a discrete pattern of altered behavioral, thought, and mood profile in comparison with healthy controls and with idiopathic epilepsy patients thus suggesting a direct link with sleepiness. Further studies investigating behavior in patients with idiopathic hypersomnia or type 2 narcolepsy are needed to disentangle the role of REM sleep dysfunction and hypocretin deficiency in psychiatric disorders. Symptoms of withdrawal, depression, somatic complaints, thought problems, and aggressiveness were common, NT1 children perceived lower school competencies than healthy children, and their parents also reported worse psychosocial health. Our data suggest that early effective treatment and disease self-awareness should be promoted in NT1 children for their positive effect on behavior and psychosocial health.
© 2016 Associated Professional Sleep Societies, LLC.

Entities:  

Keywords:  attention deficit/hyperactivity disorder; narcolepsy with cataplexy; psychiatry; quality of life

Mesh:

Year:  2016        PMID: 27166243      PMCID: PMC4909621          DOI: 10.5665/sleep.5970

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  61 in total

1.  A CASE OF NARCOLEPSY WITH PSYCHOSIS (PARANOID STATE OF NARCOLEPSY).

Authors:  H Z COREN; J J STRAIN
Journal:  Compr Psychiatry       Date:  1965-06       Impact factor: 3.735

2.  Narcolepsy and psychiatry: an evolving association of increasing interest.

Authors:  H A Droogleever Fortuyn; P C Mulders; W O Renier; J K Buitelaar; S Overeem
Journal:  Sleep Med       Date:  2011-08       Impact factor: 3.492

3.  Narcolepsy and schizophrenia.

Authors:  K C Ullman
Journal:  Am J Psychiatry       Date:  1977-07       Impact factor: 18.112

4.  Clinical, polysomnographic and laboratory characteristics of narcolepsy-cataplexy in a sample of children and adolescents.

Authors:  Rosa Peraita-Adrados; Juan J García-Peñas; Luz Ruiz-Falcó; Luis Gutiérrez-Solana; Pilar López-Esteban; José L Vicario; Silvia Miano; Manuel Aparicio-Meix; María-José Martinez-Sopena
Journal:  Sleep Med       Date:  2010-11-02       Impact factor: 3.492

5.  A clinical picture of child and adolescent narcolepsy.

Authors:  R E Dahl; J Holttum; L Trubnick
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994 Jul-Aug       Impact factor: 8.829

6.  Psychosis risk screening in clinical high-risk adolescents: a longitudinal investigation using the Child Behavior Checklist.

Authors:  Diana I Simeonova; Theresa Nguyen; Elaine F Walker
Journal:  Schizophr Res       Date:  2014-08-27       Impact factor: 4.939

7.  Problems in the differential diagnosis of narcolepsy versus schizophrenia.

Authors:  B Shapiro; H Spitz
Journal:  Am J Psychiatry       Date:  1976-11       Impact factor: 18.112

8.  Pharmacologic and psychotherapeutic issues in coexistent paranoid schizophrenia and narcolepsy: case report.

Authors:  R J Cadieux; J D Kales; A Kales; J Biever; L D Mann
Journal:  J Clin Psychiatry       Date:  1985-05       Impact factor: 4.384

9.  Psychosocial and intellectual functioning in childhood narcolepsy.

Authors:  Liam Dorris; Sameer M Zuberi; Nicola Scott; Catriona Moffat; Irene McArthur
Journal:  Dev Neurorehabil       Date:  2008-07       Impact factor: 2.308

10.  The Italian version of the PedsQL in children with rheumatic diseases.

Authors:  M Trapanotto; D Giorgino; F Zulian; F Benini; J W Varni
Journal:  Clin Exp Rheumatol       Date:  2009 Mar-Apr       Impact factor: 4.473

View more
  9 in total

1.  Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy Diagnosis.

Authors:  Zhongxing Zhang; Yves Dauvilliers; Giuseppe Plazzi; Geert Mayer; Gert Jan Lammers; Joan Santamaria; Markku Partinen; Sebastiaan Overeem; Rafael Del Rio Villegas; Karel Sonka; Rosa Peraita-Adrados; Raphaël Heinzer; Aleksandra Wierzbicka; Birgit Högl; Mauro Manconi; Eva Feketeova; Antonio Martins da Silva; Jitka Bušková; Claudio L A Bassetti; Lucie Barateau; Fabio Pizza; Elena Antelmi; Jari K Gool; Rolf Fronczek; Carles Gaig; Ramin Khatami
Journal:  Nat Sci Sleep       Date:  2022-05-31

Review 2.  Associations Between Neuropsychological, Neurobehavioral and Emotional Functioning and Either Narcolepsy or Idiopathic Hypersomnia in Children and Adolescents.

Authors:  Beris Ludwig; Simon Smith; Helen Heussler
Journal:  J Clin Sleep Med       Date:  2018-04-15       Impact factor: 4.062

3.  Family functioning among adolescents with narcolepsy.

Authors:  Arpita Parmar; Eluen Ann Yeh; Daphne J Korczak; Shelly K Weiss; Zihang Lu; Allison Zweerink; Alene Toulany; Brian J Murray; Indra Narang
Journal:  Paediatr Child Health       Date:  2019-01-11       Impact factor: 2.253

4.  Perceived challenges in pediatric narcolepsy: a survey of parents, youth, and sleep physicians.

Authors:  David G Ingram; Lindsay Jesteadt; Claire Crisp; Stacey L Simon
Journal:  J Clin Sleep Med       Date:  2021-01-01       Impact factor: 4.062

5.  Treatment cost of narcolepsy with cataplexy in Central Europe.

Authors:  Petra Maresova; Michal Novotny; Blanka Klímová; Kamil Kuča
Journal:  Ther Clin Risk Manag       Date:  2016-11-18       Impact factor: 2.423

6.  Autism Spectrum Disorder and Narcolepsy: A Possible Connection That Deserves to Be Investigated.

Authors:  Annio Posar; Paola Visconti; Vincenza Blunda; Fabio Pizza; Giuseppe Plazzi
Journal:  Front Psychiatry       Date:  2020-04-08       Impact factor: 4.157

7.  The Xyrem® (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017.

Authors:  Michael J Strunc; Jed Black; Prasheel Lillaney; Judi Profant; Sherice Mills; Shay Bujanover; Michael J Thorpy
Journal:  Drugs Real World Outcomes       Date:  2021-01-13

Review 8.  Symptom measures in pediatric narcolepsy patients: a review.

Authors:  Hui Ouyang; Xuguang Gao; Jun Zhang
Journal:  Ital J Pediatr       Date:  2021-06-02       Impact factor: 2.638

9.  The development of a health-related quality-of-life instrument for young people with narcolepsy: NARQoL-21.

Authors:  John E Chaplin; Attila Szakács; Tove Hallböök; Niklas Darin
Journal:  Health Qual Life Outcomes       Date:  2017-07-04       Impact factor: 3.186

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.